Search research articles
Contact Us
Filters
Showing results (221-230 of 244) with videos related to
Page
of 25
Sort By:
Blood Advances
|
October 22, 2025
Prognostic Value of Inflammation-Based Scores in R/R LBCL Patients Treated with CD3xCD20 Bispecific T-Cell Engagers
Giulia Magno, Kai Rejeski, Giulia Rappa, et al.
Blood Cancer Journal
|
August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma
Michael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Journal of Hematology & Oncology
|
December 9, 2022
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
Bijal D Shah, Armin Ghobadi, Olalekan O Oluwole, et al.
Blood
|
July 19, 2021
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
Christian Augsberger, Gerulf Hänel, Wei Xu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2024
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects
Carolin Ertl, Theresa Ruf, Dirk Mentzer, et al.
Blood Advances
|
December 11, 2024
Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study
Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff, et al.
Blood Cancer Discovery
|
January 9, 2024
Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma
Rawan G Faramand, Sae Bom Lee, Michael D Jain, et al.
Hemasphere
|
July 8, 2021
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
Erik Gaitzsch, Verena Passerini, Elham Khatamzas, et al.
Blood
|
June 10, 2023
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, et al.
Blood Advances
|
August 19, 2025
International Consensus Guidelines for the Conduct and Reporting of CAR T-Cell Clinical Trials in AML
Swati Naik, Richard Aplenc, Susanne H C Baumeister, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 244) with videos related to
Sort By:
Page
of 25
Blood Advances
|
October 22, 2025
Prognostic Value of Inflammation-Based Scores in R/R LBCL Patients Treated with CD3xCD20 Bispecific T-Cell Engagers
Giulia Magno, Kai Rejeski, Giulia Rappa, et al.
Blood Cancer Journal
|
August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma
Michael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Journal of Hematology & Oncology
|
December 9, 2022
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
Bijal D Shah, Armin Ghobadi, Olalekan O Oluwole, et al.
Blood
|
July 19, 2021
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
Christian Augsberger, Gerulf Hänel, Wei Xu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2024
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects
Carolin Ertl, Theresa Ruf, Dirk Mentzer, et al.
Blood Advances
|
December 11, 2024
Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study
Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff, et al.
Blood Cancer Discovery
|
January 9, 2024
Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma
Rawan G Faramand, Sae Bom Lee, Michael D Jain, et al.
Hemasphere
|
July 8, 2021
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
Erik Gaitzsch, Verena Passerini, Elham Khatamzas, et al.
Blood
|
June 10, 2023
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, et al.
Blood Advances
|
August 19, 2025
International Consensus Guidelines for the Conduct and Reporting of CAR T-Cell Clinical Trials in AML
Swati Naik, Richard Aplenc, Susanne H C Baumeister, et al.
Page
of 25